With respect to histomorphology, our results show that the rate of EGFR mutations is highest (82.4%) in adenocarcinoma, followed by squamous cell carcinoma (7.9%) and other types of lung carcinomas (10.27%). This evidence concerns the gene EGFR and lung carcinoma.